DE60221348D1 - Substituierte chinoline zur behandlung von durch protozoen und retroviren verursachten co-infektionen - Google Patents

Substituierte chinoline zur behandlung von durch protozoen und retroviren verursachten co-infektionen

Info

Publication number
DE60221348D1
DE60221348D1 DE60221348T DE60221348T DE60221348D1 DE 60221348 D1 DE60221348 D1 DE 60221348D1 DE 60221348 T DE60221348 T DE 60221348T DE 60221348 T DE60221348 T DE 60221348T DE 60221348 D1 DE60221348 D1 DE 60221348D1
Authority
DE
Germany
Prior art keywords
sub
alkenyl
retrovirus
alkynyl
chinolines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60221348T
Other languages
English (en)
Other versions
DE60221348T2 (de
Inventor
Mohamed Fakhfakh
Bruno Figadere
Alain Fournet
Xavier Franck
Reynald Hocquemiller
Eric Prina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut de Recherche pour le Developpement IRD
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut de Recherche pour le Developpement IRD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut de Recherche pour le Developpement IRD filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE60221348D1 publication Critical patent/DE60221348D1/de
Application granted granted Critical
Publication of DE60221348T2 publication Critical patent/DE60221348T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE60221348T 2001-01-17 2002-01-15 Substituierte chinoline zur behandlung von durch protozoen und retroviren verursachten co-infektionen Expired - Lifetime DE60221348T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0100580A FR2819507B1 (fr) 2001-01-17 2001-01-17 Quinoleines substituees pour le traitement de co-infections a protozoaires et a retrovirus
FR0100580 2001-01-17
PCT/FR2002/000140 WO2002057238A1 (fr) 2001-01-17 2002-01-15 Quinoleines substituees pour le traitement de co-infections a protozoaires et a retrovirus

Publications (2)

Publication Number Publication Date
DE60221348D1 true DE60221348D1 (de) 2007-09-06
DE60221348T2 DE60221348T2 (de) 2008-04-10

Family

ID=8858905

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60221348T Expired - Lifetime DE60221348T2 (de) 2001-01-17 2002-01-15 Substituierte chinoline zur behandlung von durch protozoen und retroviren verursachten co-infektionen

Country Status (9)

Country Link
US (1) US7342026B2 (de)
EP (1) EP1351940B1 (de)
AT (1) ATE368030T1 (de)
BR (1) BR0206552A (de)
CA (1) CA2434063C (de)
DE (1) DE60221348T2 (de)
ES (1) ES2291438T3 (de)
FR (1) FR2819507B1 (de)
WO (1) WO2002057238A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0603871B8 (pt) * 2006-08-24 2021-05-25 Fundacao Univ De Brasilia composições farmacêuticas para o tratamento de tripanossomíases e de doença de chagas
SI2220076T1 (sl) * 2007-11-15 2012-05-31 Gilead Sciences Inc Inhibitorji replikacije virusa humane imunske pomankljivosti
KR20100108337A (ko) * 2007-11-15 2010-10-06 베링거 인겔하임 인터내셔날 게엠베하 사람 면역결핍 바이러스 복제의 억제제
US8461180B2 (en) * 2007-11-16 2013-06-11 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication
EA019259B1 (ru) * 2007-11-16 2014-02-28 Джилид Сайенсиз, Инк. Ингибиторы репликации вируса иммунодефицита человека
FR2929943B1 (fr) * 2008-04-15 2010-09-24 Inst Rech Developpement Ird Sels de quinoleines 2-substituees
FR2931479B1 (fr) * 2008-05-20 2012-12-07 I R D Nouveaux derives de quinoleines 2-substituees et un procede pour leur preparation
FR2933977B1 (fr) * 2008-07-18 2013-04-26 Centre Nat Rech Scient Derives heterocycliques utiles dans le traitement des maladies neurodegeneratives
WO2010144101A1 (en) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Next generation quinoloine methanols
AU2011274322B2 (en) 2010-07-02 2015-08-13 Gilead Sciences, Inc. Naphth- 2 -ylacetic acid derivatives to treat AIDS
WO2012003498A1 (en) * 2010-07-02 2012-01-05 Gilead Sciences, Inc. 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
PE20141066A1 (es) 2011-04-21 2014-09-05 Gilead Sciences Inc Compuestos de benzotiazol
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
BR112014018990A8 (pt) 2012-04-20 2017-07-11 Gilead Sciences Inc Derivados de ácido benzotiazol-6-il acético e seu uso para tratamento de uma infecção
CN102690042A (zh) * 2012-05-28 2012-09-26 常熟市建华模具有限责任公司 一种用于制作玻璃容器用的模具
CN105452224B (zh) * 2013-04-02 2017-12-26 安基生技新药股份有限公司 作为抗神经退化剂的多官能性喹啉衍生物
US9302992B2 (en) 2013-04-02 2016-04-05 Annji Pharmaceutical Co., Ltd. Multifunctional quinoline derivatives as anti-neurodegenerative agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH471810A (de) * 1964-10-22 1969-04-30 Ciba Geigy Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
EP0206751A3 (de) * 1985-06-18 1988-05-25 Merck Frosst Canada Inc. 2-Substituierte Chinoline, ihre Herstellung und Verwendung
IL83715A0 (en) * 1987-08-31 1988-01-31 Yeda Res & Dev Pharmaceutical anti-protozoal compositions
US5153202A (en) * 1988-06-30 1992-10-06 Davis Michael H Method of inhibiting the activity of human immuno deficiency virus (HIV) in vivo
US5278173A (en) * 1988-06-30 1994-01-11 Davis Michael H Method of inhibiting the activity of human immunodeficiency virus (HIV) in vivo
US5360811A (en) * 1990-03-13 1994-11-01 Hoechst-Roussel Pharmaceuticals Incorporated 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds as anti-inflammatory agents
FR2682107B1 (fr) * 1991-10-03 1995-04-21 Orstom Inst Fs Rech Scient Quinoleines 2-substituees pour le traitement des leishmanioses.
GB9614347D0 (en) * 1996-07-09 1996-09-04 Smithkline Beecham Spa Novel compounds
FR2761687B1 (fr) 1997-04-08 2000-09-15 Centre Nat Rech Scient Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
EP1155698A4 (de) * 1999-01-29 2003-01-15 Nitto Kasei Co Ltd Organoborverbindungen mit antikokzidischer aktivität
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
AU7511800A (en) * 1999-08-30 2001-03-26 K.U. Leuven Research And Development Novel target for antiparasitic agents and inhibitors thereof

Also Published As

Publication number Publication date
EP1351940B1 (de) 2007-07-25
US7342026B2 (en) 2008-03-11
CA2434063C (fr) 2011-08-02
ES2291438T3 (es) 2008-03-01
CA2434063A1 (fr) 2002-07-25
WO2002057238A1 (fr) 2002-07-25
US20050165052A1 (en) 2005-07-28
ATE368030T1 (de) 2007-08-15
FR2819507B1 (fr) 2007-09-28
FR2819507A1 (fr) 2002-07-19
DE60221348T2 (de) 2008-04-10
EP1351940A1 (de) 2003-10-15
BR0206552A (pt) 2004-03-23

Similar Documents

Publication Publication Date Title
DE60221348D1 (de) Substituierte chinoline zur behandlung von durch protozoen und retroviren verursachten co-infektionen
ATE366724T1 (de) Kondensierte heterocyclische derivate
BR9810829A (pt) Composto, processo para preparar o mesmo, composição, uso de um composto ou um sal farmaceuticamente aceitável do mesmo ou uma composição, e, processo de tratamento de uma condição
ATE381542T1 (de) Nr1h4-kern-rezeptor-bindende verbindungen
HUP0402310A2 (hu) 1,6-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények
NO20062644L (no) DPP-IV inhibitorer
CA2383409A1 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
DK0769010T3 (da) 2-[1',2',4'-triazol-3'-yloxymethylen]-anilider og deres anvendelse som pesticider
ATE291578T1 (de) Pyrazolylsubstituierte thienyloxy-pyridine
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
PT1063228E (pt) Derivados de cicloalcenos processo para a sua preparacao e utilizacao
NO20063865L (no) Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
UA85502C2 (en) Diazaindole-dicarbonyl-piperazinyl antiviral agents
DK1970372T3 (da) Salte af 9-oxoacridin-10-eddikesyre med 1-alkylamino-1-deoxy-polyoler
ATE457305T1 (de) Neue 3-phenylpropionsäurederivate zur behandlung von diabetes
MA27649A1 (fr) Derives d'acylphenyluree substitues par carbonylamino, methode de production et d'utilisation de ceux-ci.
BR0317259A (pt) Complexos de e-2-metóxi-n-(3-{4-[3-metil-4-(6-metilpiridin-3-ilóxi)-fenil amino]- quinazolin-6-il}-alil)-acetamida, seus métodos de produção e utilização
DE50101360D1 (de) Verwendung von 2-phenylendiaminderivaten zur behandlung von infektionen
PT1347960E (pt) Processo para a preparacao de (+)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperidina
NO20030500L (no) Dihydroporfyrinderivater og deres anvendelse
RU2004103857A (ru) Производные вариолина и их применение в качестве противоопухолевых средств
BR0212243A (pt) Compostos de alqueno di e trifluorossubstituìdos, processo para a preparação e uso dos mesmos, métodos para o controle de nematódeos ou aracnìdeos para a proteção de plantas de infestação ou ataque por neumatódeos ou aracnìdeos, para o tratamento, controle, prevenção ou proteção de animais de sangue quente ou peixe contra infestação ou infecção por endo ou ectoparasitas helmintos, aracnìdeos ou artrópodes, e para a preparação de uma composição, e, composição para o controle de nematódeos ou aracnìdeos
DE60208347D1 (de) Verwendung von "xylyloxy alkyl amines" für die Behandlung von Tinnitus
TH83171B (th) วิธีการของการสังเคราะห์อนุพันธ์ 6-แอลคิลอะมิโนควิโนลีน
RU2003110579A (ru) Гетероциклические соединения, связывающие хемокиновый рецептор

Legal Events

Date Code Title Description
8364 No opposition during term of opposition